TheEdgeResearch
Home / Stocks / SGMT

Sagimet Biosciences Inc. (SGMT)

NASDAQ Healthcare Biotechnology
$9.08 ▼ -5.61%
Market Cap
$648.0M
Sector
Healthcare
Industry
Biotechnology
Beta
3.47
52-Wk Range
4.5-11.45
CEO
David Happel
Country
US
Currency
USD

Sagimet Biosciences Inc. operates in the Biotechnology industry of the Healthcare sector, headquartered in San Mateo, CA, US. The stock last traded at $9.08, down 5.61% on the session, giving a market capitalisation of $648.0M. On trailing twelve-month figures it carries a trailing P/E of -7.63, a net margin of 0.0%. Its beta of 3.47 implies it has historically moved more than the broad market.

Valuation & profitability (TTM)
P/E
-7.63
Price / Sales
0.00
Price / Book
2.34
EV / EBITDA
-9.64
Gross margin
0.0%
Operating margin
0.0%
Net margin
0.0%
Return on equity
—
Debt / equity
0.01
Current ratio
6.34
Dividend yield
0.0%
Payout ratio
0.0%
Company profile
Exchange
NASDAQ
Employees
16
IPO date
2023-07-14
Headquarters
San Mateo, CA, US
About Sagimet Biosciences Inc.

Sagimet Biosciences Inc., a clinical-stage biopharmaceutical company, develops novel therapeutics called fatty acid synthase (FASN) inhibitors for the treatment of diseases that result from dysfunctional metabolic and fibrotic pathways in the United States. The company’s lead drug candidate is Denifanstat, an oral, once-daily pill and selective FASN inhibitor for the treatment of metabolic dysfunction-associated steatohepatitis, acne, and select forms of cancer. It also develops TVB-3567, a FASN inhibitor for the treatment of acne indication; and other oncology programs, such as solid tumor and glioblastoma. The company was formerly known as 3-V Biosciences, Inc. and changed its name to Sagimet Biosciences Inc. in August 2019. Sagimet Biosciences Inc. was incorporated in 2006 and is headquartered in San Mateo, California.

Comparable companies

Sagimet Biosciences Inc. is most often compared with the following Healthcare names:

ACHVARCTASMBAVIRFHTXHUMAIMRXTRDAVYGRZURA
More research on SGMT
SGMT technical analysis SGMT TheEdge Score Compare against peers
Open full interactive analysis & DCF →